Skip to content
MMMAA5AA5AA5

Drawing based on the label description. No photo yet.

“The 5 mg/20 mg tablets are white to off-white, film-coated, round, unscored tablets debossed with M on one side of the tablet and AA5 on the other side”

M AA5 pill

Pill with imprint M AA5 is white, round, 8 mm and has been identified as Amlodipine and Atorvastatin 5 mg / 20 mg. It is used for high blood pressure. It is supplied by Mylan Pharmaceuticals Inc.

Amlodipine and Atorvastatin 5 mg / 20 mg

Imprint
M AA5
Strength
Amlodipine 5 mg / Atorvastatin 20 mg
Used for
High blood pressure
Color
White
Shape
Round
Size
8 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Mylan Pharmaceuticals Inc
Drug class
Calcium channel blocker (blood pressure and heart medicine)
NDC
0378-4514, 0378-4514-93

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Amlodipine and Atorvastatin pills and guides

What is Amlodipine and Atorvastatin used for?

Amlodipine and Atorvastatin is used for high blood pressure.

Medicine type
Calcium channel blocker (blood pressure and heart medicine); statin (cholesterol medicine)
Official uses from the US prescribing label

CADUET (amlodipine and atorvastatin) is indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate.

Amlodipine

Hypertension

Amlodipine is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Amlodipine may be used alone or in combination with other antihypertensive agents.

Coronary Artery Disease (CAD)

Chronic Stable Angina

Amlodipine is indicated for the symptomatic treatment of chronic stable angina. Amlodipine may be used alone or in combination with other antianginal agents.

Vasospastic Angina (Prinzmetal’s or Variant Angina)

Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine may be used as monotherapy or in combination with other antianginal agents.

Angiographically Documented CAD

In patients with recently documented CAD by angiography and without heart failure or an ejection fraction < 40%, amlodipine is indicated to reduce the risk of hospitalization for angina and to reduce the risk of a coronary revascularization procedure.

Atorvastatin

Atorvastatin is indicated:

  • To reduce the risk of:
    • Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD
    • MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD
    • Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD
  • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in:
    • Adults with primary hyperlipidemia.
    • Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH).
  • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH).
  • As an adjunct to diet for the treatment of adults with:
    • Primary dysbetalipoproteinemia
    • Hypertriglyceridemia

From the FDA-approved label on DailyMed (published Oct 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows M and the other side shows AA5.
  • It is white, round, 8 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Amlodipine Besylate, Atorvastatin Calcium Trihydrate

Inactive: Sodium Carbonate, Silicon Dioxide, Croscarmellose Sodium, Hydroxypropyl Cellulose, Unspecified, Arginine, Lecithin, Soybean, Magnesium Stearate, Microcrystalline Cellulose, Polyvinyl Alcohol, Unspecified, Starch, Corn, Talc, Titanium Dioxide, Xanthan Gum

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Amlodipine and Atorvastatin pills